Lanean...
Cost-effectiveness of Sorafenib for Treatment of Advanced Hepatocellular Carcinoma in India
BACKGROUND: Majority of patients of hepatocellular carcinoma (HCC) in India present in advanced stages, when curative treatment options are limited. We undertook this study to assess the cost-effectiveness of treating advanced HCC patients with sorafenib compared with best supportive care (BSC). MET...
Gorde:
| Argitaratua izan da: | J Clin Exp Hepatol |
|---|---|
| Egile Nagusiak: | , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Elsevier
2019
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6728525/ https://ncbi.nlm.nih.gov/pubmed/31516263 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jceh.2018.10.003 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|